Commentary|Podcasts|January 20, 2025
Reaching Diverse Patient Populations With Personalized Treatment Methods
Author(s)Andy Studna, Senior Editor
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses:
- Industry’s greatest challenges in reaching diverse patient populations
- Personalized treatment methods
- Recruitment strategies
- and more!
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Moving Beyond Historical Site Data to Real-Time Patient Insight
2
How Community Sites Can Stay Competitive Under Growing Efficiency Pressures
3
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up
4
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
5